Evidence map›Paper›PMID 41516211›Full record

ArticleInternational journal of molecular sciences2025

Modulation of Mast Cell Activation via MRGPRX2 by Natural Oat Extract.

Susanne Kaesler, Désirée Argiriu, Shyami M Kandage, Karla Schönfeldt, Shalva Lekiashvili, Ceren N Dengiz, Neslim Ercan, Caterina Iuliano, Martina Herrmann, Maria Reichenbach and 5 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Susanne KaeslerDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.ORCID 0000-0002-4029-7895
Désirée ArgiriuDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Shyami M KandageDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Karla SchönfeldtDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Shalva LekiashviliDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Ceren N DengizDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Neslim ErcanDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Caterina IulianoDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Martina HerrmannGlobal Innovation Cosmetic Ingredients, Symrise AG, 37603 Holzminden, Germany.
Maria ReichenbachGlobal Innovation Cosmetic Ingredients, Symrise AG, 37603 Holzminden, Germany.ORCID 0000-0002-9999-9816
Dominik CichowskiDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Magda BabinaInstitute of Allergology, Charite-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.ORCID 0000-0002-4500-7615
Miriam HilsDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.
Martin KöberleDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.ORCID 0000-0001-6825-2667
Tilo BiedermannDepartment of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, 80802 Munich, Germany.ORCID 0000-0002-5352-5105

Funding

German Research Foundation (DFG) BA-3769/4German Research Foundation (DFG) CRC1371 (project P06)German Research Foundation (DFG) RTG2668, project A2 and A3 project-ID: 435874434
6 · The paper itself

Abstract

The Mas-related G protein-coupled receptor (MRGPR) X2 is expressed on skin mast cells and can be stimulated by an unusually broad spectrum of ligands, including specific drugs and even endogenous peptides. MRGPRX2 activation can induce mast cell degranulation and consequently mediator release, leading to inflammatory and hypersensitivity reactions. In addition, MRGPRX2 mediates pain and itching sensations, leading to increased efforts to identify MRGPRX2 inhibitors, including plant-derived compounds. Components within oat extracts have been shown to mediate anti-inflammatory and itch-relieving properties, but a possible inhibitory effect on MRGPRX2 activation has not yet been investigated. We aimed to fill this gap and explored whether an oat kernel extract can modulate MRGPRX2 activation. For this purpose, we established a mast cell model with the human LAD2 cell line and used it to investigate the consequences of exposure to oat extract. While we did not observe any influence on cell viability, we analyzed the impact of oat extract on MRGPRX2-mediated mast cell activation and degranulation initiated by the three confirmed MRGPRX2 ligands c48/80, substance P, and cortistatin 14. Exposure to oat extract resulted in a significant reduction in mast cell degranulation for all three ligands, as assessed by the release of β-hexosaminidase, tryptase, cell surface expression of CD63 and CD107a, and phosphorylation of ERK. All results were confirmed with primary human mast cells. Thus, we demonstrated for the first time that oat extract leads to a significant reduction in MRGPRX2 activation, pointing to a previously unrecognized capacity of natural compounds to modulate this pathway.

Indexed as

AvenaMast CellsNerve Tissue ProteinsPlant ExtractsReceptors, G-Protein-CoupledReceptors, NeuropeptideCell DegranulationCell LineHumansPhosphorylationMRGPRX2 protein, humanNerve Tissue ProteinsPlant ExtractsReceptors, G-Protein-CoupledReceptors, Neuropeptidemast cellsMRGPRX2oat extract

Identifiers

PMID41516211
PMCPMC12786182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.